Join to access to all OVN content. Join for Free
Career Satisfaction and Growth: What factors MUST be considered
MSL career satisfaction company culture evaluation aligning core values effective company research MSL roles evolution

Career Satisfaction and Growth: What factors MUST be considered


Share This Article


Summary

In this episode, Tom Caravela is joined by Beth Kupferer to discuss career satisfaction and adaptation in the MSL field. Beth shares insights from her career journey, emphasizing the importance of evaluating leadership, company culture, and aligning with core values. The conversation delves into effective company research and key interview questions. Beth and Tom explore the evolution of MSL roles and team structures post-COVID, highlighting the significance of networking and adapting to KOL preferences. They also discuss the value of live meetings and conferences in the current landscape. The episode concludes with listener appreciation and a request for feedback.

My guest today is Beth Kupferer, National Director, Women’s Health at AbbVie, and we discuss the factors most important for career satisfaction and growth

Beth discusses…

👉 What people need to know when determining next steps for their careers
👉 How people should research companies prior to making the decision to join
👉 What people should be looking for in a company
👉 What MSLs can do to help grow their career
👉 How critical it is for company values to align with personal values
👉 Questions to prepare and ask during an interview

Click for Source
MSL career satisfaction, company culture evaluation, aligning core values, effective company research, MSL roles evolution

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Article
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
OVN Avatar Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Article
Clinical Educator Oncology Program Improves Adherence by 29%​
Partner Avatar iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%​

Article
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
OVN Avatar Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN